American Hospital Dubai introduces no surgery, no radiation treatment for prostate cancer patients
American Hospital Dubai introduces the region's first Focal One® Robotic High-Intensity Focused Ultrasound (HIFU) procedures for prostate cancer patients. The state-of-the-art technology uses ultra-precise, high-intensity, focused ultrasound waves to destroy malignant tissue in the prostate while preserving the healthy surrounding tissue. The concentration of the ultrasound waves at super-localised spots in the prostate creates heat that kills the cancerous cells.
American Hospital Dubai is the first private healthcare provider to bring this highly advanced, state-of-the-art robotic treatment option to the region, further strengthening its robotic surgery excellence and its commitment to providing the most advanced robotic medical care in the UAE and the region.
A groundbreaking HIFI study in 2024, published in the prestigious European Urology journal, demonstrated HIFU's effectiveness and efficacy. The study concluded that HIFU achieves oncological outcomes comparable to traditional surgery, while delivering superior functional results. The study was the most extensive prospective comparative oncological clinical study to compare prostate cancer treatments.
The Focal One® Robotic HIFU is a boon for patients seeking prostate cancer treatment without the stress of surgery, cutting or radiation. The procedure is non-invasive and can be completed in a single session under general anesthesia, reducing the risk of side effects such as incontinence or erectile dysfunction. Focal One's® Dynamic Focusing Probe, which produces ultrasound waves, delivers high-resolution real-time ultrasound imaging covering an expanded area and ablating three times faster than other technologies, proving a valuable advantage for surgeons and patients.
Focal One® Robotic HIFU procedure is an advantage for patients and healthcare teams. It reduces overall treatment costs through shortened hospital stays, quicker recovery times, and minimum complications compared to traditional prostate surgery.
Adding Focal One® Robotic HIFU to American Hospital Dubai's dedicated Prostate Clinic further consolidates the Clinic's role as a one-stop, state-of-the-art facility in the region offering a full range of diagnostics and treatments for all prostate-related conditions. The Clinic provides the best turnaround time (TAT) with same-day prostate testing and diagnosis and same-day consultation to devise the best treatment plan for patients.
American Hospital Dubai's excellence in robotic surgery has earned its Center of Excellence in Robotic Surgery (COERS) accreditation from the US-based Surgical Review Corporation (SRC). The hospital is the first private healthcare facility in the region to earn this recognition.
Sherif Beshara, group CEO of American Hospital Dubai, said: 'We are excited to introduce the revolutionary Focal One® Robotic HIFU to the region. At American Hospital Dubai, we are committed to bringing patients the latest medical advancements. Focal One® Robotic HIFU technology reinforces our dedication to delivering world-class care while prioritising patient quality of life. We are renowned for our excellence in robotic surgeries, and Focal One® Robotic HIFU iterates our patient-centric care values.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sharjah 24
13 hours ago
- Sharjah 24
UAE committed to ocean protection and sustainability
Oceans: Vital yet under threat On World Oceans Day, Dr Al Dahak stated: 'Covering more than 70 percent of the Earth's surface, our oceans are undeniably essential to human lives and livelihoods. They are the lifeblood of our planet, regulating our climate, providing sustenance, and supporting countless ecosystems. We recognise, however, that our oceans face unprecedented challenges. From the impacts of climate change, evidenced by coral bleaching and rising sea levels, to the pressures of unsustainable fishing practices, the health of our oceans is at risk.' UAE's strategic response She added, 'As a nation deeply connected to the sea, we understand the urgency of these challenges and are committed to leading the way in finding solutions. We recognise the responsibility we have to safeguard these resources for future generations, and we are actively implementing strategies to mitigate these threats and restore the health of our marine ecosystems.' Embracing the spirit of World Oceans Day Dr Al Dahak noted that this year's World Oceans Day is celebrated under the theme "Wonder: Sustaining What Sustains Us", aligning closely with the UAE's vision for a sustainable future. She highlighted initiatives such as a coral rehabilitation project to outplant over 4 million coral colonies in UAE waters by 2030 and efforts to reach the goal of planting 100 million mangroves by 2030. International cooperation for ocean sustainability Dr Al Dahak also emphasized the UAE's international role, stating: 'Our commitment extends beyond our national waters. The UAE is proud to be the first nation in the Middle East to join the '100% Alliance,' a UN initiative by the High-Level Panel for a Sustainable Ocean Economy, calling on coastal states to commit to sustainable management of all ocean areas under their jurisdiction.' A call to action Concluding her message, Dr Al Dahak urged: 'On this World Oceans Day, I urge each of you to become an ocean advocate. Learn about sustainable seafood choices. Reduce your plastic consumption. Support organisations dedicated to ocean conservation. Instil in your children a love of the oceans and teach them about the wonders of our seas. Every action, no matter how small, makes a difference. Let's work together to restore the vibrancy of our oceans. Let's ensure that the 'Wonder' of the ocean endures.'
Arabian Post
4 days ago
- Arabian Post
TikTok Eliminates #SkinnyTok Amid Mounting Pressure Over Harmful Diet Content
TikTok has removed the hashtag #SkinnyTok from its platform, responding to escalating concerns over content promoting extreme weight loss and disordered eating behaviours. Users searching for the term are now redirected to resources offering support for body image and eating disorders. The decision follows sustained scrutiny from European regulators, particularly in France, where officials have criticised the platform for enabling the spread of content that glamorises unhealthy body standards. Clara Chappaz, France's Minister for Digital Affairs, characterised the removal as a 'collective victory' and reiterated her commitment to safeguarding minors online. TikTok stated that the hashtag had become associated with content violating its community guidelines by promoting dangerous dieting practices, including extreme calorie restriction and excessive water consumption. Although the platform had previously attempted to mitigate exposure by restricting such content to users over 18 and adjusting search suggestions, many harmful videos continued to circulate. ADVERTISEMENT The platform has faced criticism for featuring influencers like Liv Schmidt, who promoted these dangerous practices. Her content was eventually removed after media scrutiny, and she later lost her monetisation privileges on Instagram as well. Despite the removal of the hashtag, concerns persist. Typing 'SkinnyTok' into the app now redirects users to wellness advice, but similar harmful content still thrives under altered or misspelled hashtags. Advocates argue that while the ban is a positive step, it is insufficient to address the broader issue of harmful content on the platform. TikTok's actions come amid a broader push by the European Union to hold social media platforms accountable for harmful content. The European Commission has been investigating TikTok's risk management of addictive design and harmful content since February 2024. The platform's decision to ban #SkinnyTok may be seen as an effort to demonstrate compliance with regulatory expectations. Experts warn that the proliferation of content promoting disordered eating on social media platforms like TikTok can have serious consequences for young users' mental health. Studies have shown that exposure to such content can lead to increased body dissatisfaction and a higher risk of developing eating disorders. Health professionals emphasise the need for more robust content moderation and greater awareness of the dangers posed by these online communities.
Al Etihad
6 days ago
- Al Etihad
M42, AstraZeneca, SOPHiA GENETICS to transform cancer diagnosis, care
3 June 2025 14:30 ABU DHABI (ALETIHAD)M42, a global health leader powered by technology, announced a strategic collaboration with AstraZeneca and SOPHiA GENETICS to bring cutting-edge liquid biopsy testing to the UAE, aimed at advancing cancer diagnosis, informing treatment decisions, and enabling faster, accurate biomarker testing across a broad range of part of the collaboration, M42 will integrate SOPHiA GENETICS' MSK-ACCESS®, powered with SOPHiA DDM™ technology, into its testing infrastructure, enabling non-invasive genomic profiling of cancers through a simple blood approach does not replace but rather complements routine cancer screenings, and is designed for patients who are unable to undergo a solid tumor biopsy, enabling them to be matched with a precision therapy tailored to their specific cancer the next 12 months, the partnership will enable liquid biopsy testing access across select leading hospitals across the UAE, providing patients with faster, less invasive biomarker insights compared to traditional tissue biopsies, while also strengthening testing infrastructure and capabilities for a wide range of cancers in the new testing programme will initially target lung, ovarian, breast, colorectal, and pancreatic cancers, among others, addressing some of the most critical cancer burdens in the studies are set to commence shortly at Cleveland Clinic Abu Dhabi, marking a key milestone toward the full clinical launch planned for the latter part of Q2 El-khani, Senior Vice President, Operations, Integrated Health Solutions at M42, said, 'This collaboration reflects our vision of democratising health by making advanced diagnostics accessible to more patients, supporting not just early diagnosis but also real-time treatment monitoring and cost-effective, precise, predictive, and personalised care.'Sameh El Fangary, Cluster President GCC of AstraZeneca, stated, "Our work, and our collaborations with partners across industry, are driving towards better treatments for patients as well as a more sustainable future for healthcare systems. Through our latest partnerships, we are committed to transforming cancer care for millions in the region by advancing early diagnosis and optimising patient pathways from detection to therapy.' Ross Muken, President of SOPHiA GENETICS, said, "Expanding access to advanced testing technologies is central to our mission at SOPHiA GENETICS. Partnering with M42 and AstraZeneca in the UAE allows us to equip healthcare providers with the tools they need to personalise care, monitor disease in real-time, and ultimately improve outcomes for patients across the region." Source: Aletihad - Abu Dhabi
